News & Updates
Showing Multidisciplinary articles
Showing
Show Multimedia Only

Functional outcome improvements with atogepant sustained until 3 years
15 Jul 2026
byAudrey Abella
A 156-week safety extension study presented at EAN 2026 shows the first 3-year long-term results for atogepant in the preventive treatment of migraine in individuals with chronic migraine (CM) or episodic migraine (EM) who had an insufficient response to 2–4 classes of conventional oral, non-migraine-specific preventive migraine treatments.
Functional outcome improvements with atogepant sustained until 3 years
15 Jul 2026
Is whole goat milk formula protective against AD in infants?
14 Jul 2026
byAudrey Abella
Results from the GIraFFE* study shed light on the potential protective effect of whole goat milk formula (WGF) against the development of atopic dermatitis (AD) in infants, compared with cow milk formula (CF).







